Clear and detailed product packaging for Calvenza®-03 EIV/EHV, emphasizing its role in protecting horses from equine rhinopneumonitis and influenza. The 10-dose vial offers reliable immune support.
Calvenza®-03 EIV/EHV
by Boehringer IngelheimEquine combination vaccine to protect against EIV and EHV 1/4
- Combination vaccine for horses
- Helps prevent respiratory disease
- For healthy horses and foals at least 6 months of age
- Killed virus vaccine, no reconstitution necessary
| Catalog # | Description | Price | Qty | Autoship | CART | FAVORITES |
sc-359389 | 10 doses | $249.99 |
Click product's Autoship icon - choose frequency at Checkout.
Why Autoship?
Never forget a shipment so you're always stocked.
Saves you 5% on UltraCruz® products.
You manage the frequency or cancellation to fit your needs.
Calvenza®-03 EIV/EHV is an equine combination vaccine for the vaccination of healthy horses 6 months of age or older as an aid in the prevention of respiratory diseases caused by equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4), and equine influenza virus types A2 North American and A2 Eurasian. Calvenza®-03 EIV/EHV contains the strains Ohio/2003, Kentucky 2/95 and Newmarket 2/93 for optimum equine influenza protection. Killed virus vaccine. No mixing required. Safe for use in pregnant mares.
